Module code: INC7003-B
To develop a critical evaluative understanding of the role that cancer pharmacology plays in the development and evaluation of anti-cancer drugs in both the pre-clinical and clinical settings. Emphasis will be placed on emerging concepts that reflect the changing nature of modern drug development. The student led target evaluation exercise in the Molecular Basis of Cancer & Cancer Therapy will be extended through the evaluation of therapeutic strategies employed against these targets.
This module will cover the role played by the cancer pharmacologist in the development and evaluation of new anti-cancer drugs with the emphasis placed on modern and emerging approaches that reflect the changing nature of drug development. Topics to be covered include; biochemical and molecular pharmacology in cell free assays, pharmacokinetics and pharmacodynamics, drug delivery issues, combination therapies and drug administration issues, clinical trial design, regulatory issues required for drug registration, good laboratory practice and ethical issues related to human tissue acquisition and tissue banks. Students will also extend their literature searching and written communication skills through the preparation of drug profile reports and oral communication through presentation of a seminar.
Download the PDF for Cancer Pharmacology